Because of their tumor vasculature homing properties, CNGRCG and other NGR-peptides have been exploited for delivering a variety of therapeutic or imaging compounds to neoplastic lesions, including liposomes, chemotherapeutic agents, DNA, viruses, anti-angiogenic compounds, fluorescent molecules, contrast agents and also cytokines [12]. The gene discussed is RTN4R; the disease is neoplasm.